Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$737M |
| 2 |
American Tower
AMT
|
+$687M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$554M |
| 4 |
Abbott
ABT
|
+$553M |
| 5 |
SLB Ltd
SLB
|
+$449M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.06B |
| 2 |
Netflix
NFLX
|
+$816M |
| 3 |
Match Group
MTCH
|
+$678M |
| 4 |
NVIDIA
NVDA
|
+$611M |
| 5 |
Intuitive Surgical
ISRG
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.87% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
GrafTech
EAF
$173M
| $634K | ﹤0.01% |
8,971
-9
| -0.1% | -$784 |
|
577
FirstService
FSV
$6.48B
| $634K | ﹤0.01% |
5,231
-83
| -2% | -$10.5K |
|
578
Amkor Technology
AMKR
$12.7B
| $630K | ﹤0.01% |
37,146
-182
| -0.5% | -$3.46K |
|
|
TGNA
579
DELISTED
TEGNA Inc
TGNA
| $624K | ﹤0.01% |
+29,756
| New | +$644K |
|
580
CF Industries
CF
$19.2B
| $605K | ﹤0.01% |
+7,058
| New | +$686K |
|
581
Zumiez
ZUMZ
$329M
| $604K | ﹤0.01% |
23,218
+238
| +1% | +$8.01K |
|
582
Ethan Allen Interiors
ETD
$567M
| $597K | ﹤0.01% |
29,538
-44,929
| -60% | -$1.06M |
|
583
Deckers Outdoor
DECK
$13.4B
| $594K | ﹤0.01% |
+13,968
| New | +$610K |
|
584
Public Storage
PSA
$60.6B
| $589K | ﹤0.01% |
+1,883
| New | +$652K |
|
585
Texas Pacific Land
TPL
$27.9B
| $582K | ﹤0.01% |
+3,519
| New | +$575K |
|
586
W.W. Grainger
GWW
$65.6B
| $580K | ﹤0.01% |
+1,277
| New | +$621K |
|
|
LSXMK
587
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $576K | ﹤0.01% |
+20,628
| New | +$650K |
|
|
SAFM
588
DELISTED
Sanderson Farms Inc
SAFM
| $576K | ﹤0.01% |
+2,673
| New | +$523K |
|
589
BILL Holdings
BILL
$4.51B
| $569K | ﹤0.01% |
5,179
+1,671
| +48% | +$243K |
|
590
Warner Bros
WBD
$65.9B
| $565K | ﹤0.01% |
+42,109
| New | +$781K |
|
591
Beam Therapeutics
BEAM
$2.65B
| $556K | ﹤0.01% |
+14,359
| New | +$571K |
|
592
Nurix Therapeutics
NRIX
$2.42B
| $554K | ﹤0.01% |
43,734
-21
| -0% | -$238 |
|
|
COUP
593
DELISTED
Coupa Software Incorporated
COUP
| $549K | ﹤0.01% |
+9,622
| New | +$742K |
|
594
Marqeta
MQ
$1.83B
| $547K | ﹤0.01% |
+16,853
| New | +$663K |
|
595
NovaGold Resources
NG
$2.59B
| $545K | ﹤0.01% |
+113,360
| New | +$708K |
|
596
Welltower
WELL
$170B
| $538K | ﹤0.01% |
+6,533
| New | +$581K |
|
|
DOCU
597
DocuSign
DOCU
$10.4B
| $535K | ﹤0.01% |
+9,327
| New | +$755K |
|
598
Paylocity
PCTY
$7.32B
| $467K | ﹤0.01% |
2,679
-65
| -2% | -$11.8K |
|
599
SkinHealth Systems
SKIN
$88.1M
| $442K | ﹤0.01% |
34,397
-19,085
| -36% | -$256K |
|
600
MongoDB
MDB
$26.9B
| $437K | ﹤0.01% |
1,683
-253,948
| -99% | -$79.4M |
|
Similar funds
Jennison Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Jennison Associates held 720 positions worth $100B, down 26% from $136B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Jennison Associates withdrew a net $3.7B in Q2 2022, closing 106 positions and reducing 265 holdings. Its most notable exit was Okta, an estimated $272M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in KBR worth $40.4M.
- Jennison Associates's largest Q2 2022 buy was KBR: 834,334 shares worth $40.4M.
- Jennison Associates added most to Eli Lilly in Q2 2022, an estimated $737M increase.
- Jennison Associates's biggest Q2 2022 reduction was Shopify, cutting an estimated $1.06B.
- Jennison Associates fully exited Okta in Q2 2022, selling an estimated $272M.
- Jennison Associates's ten largest holdings make up 41% of its $100B portfolio in Q2 2022.
- Jennison Associates opened 95 new positions and closed 106 in Q2 2022.
- Jennison Associates's portfolio value fell 26% quarter-over-quarter to $100B.
Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.